• GPC3-HSP70 mRNA Nanovaccine and Anti-PD-L1 for HCC Immunity

  2026-07-13

  This study presents a novel mRNA nanovaccine encoding the GPC3127−136 cytotoxic T lymphocyte epitope fused with HSP70, designed to enhance antigen-specific immune responses against hepatocellular carcinoma (HCC). By combining the nanovaccine with anti-PD-L1 therapy, the research demonstrates a synergistic antitumor effect, advancing strategies for immunotherapy-resistant HCC.

• Nonselective β-Blockers Impair Hematopoietic Regeneration Po

  2026-07-13

  This study demonstrates that nonselective β-adrenergic receptor antagonists, such as carvedilol, impair hematopoietic regeneration in both mice and human patients following hematopoietic cell transplantation (HCT). The findings highlight the need for careful selection of β-blocker therapy in post-transplant settings, particularly when posttransplant chemotherapy is used.

• Prolonging Mouse Corneal Epithelial Proliferation with 6C Me

  2026-07-12

  This reference study introduces a novel 6C medium that sustains the proliferative potential of mouse corneal epithelial cells (mCECs) both in vitro and in vivo. By optimizing a defined combination of small molecules, including DAPT as a γ-secretase inhibitor, the paradigm enables scalable epithelial sheet generation with reduced epithelial-mesenchymal transdifferentiation. These findings have important implications for corneal regenerative medicine and limbal stem cell deficiency research.

• Optimizing Cell Assays with Angiotensin 1/2 (2-7) Peptide (A

  2026-07-10

  This article provides laboratory scientists with scenario-driven guidance on using Angiotensin 1/2 (2-7) (SKU A1050) to address key experimental challenges in cell viability, proliferation, and cytotoxicity assays. It integrates recent literature and vendor data to highlight protocol optimization, data interpretation, and product selection strategies that maximize reproducibility and research impact.

• Dasatinib Monohydrate: Benchmarks in CML Research & Kinase I

  2026-07-09

  Dasatinib Monohydrate (BMS-354825) is a potent, multitargeted kinase inhibitor with demonstrated efficacy against imatinib-resistant BCR-ABL in chronic myeloid leukemia and Ph-positive acute lymphoblastic leukemia. This dossier details its mechanistic specificity, quantitative inhibition data, and translational impact, with direct, evidence-based guidance for experimental use.

• Tamoxifen as a Selective Estrogen Receptor Modulator: Applie

  2026-07-09

  Tamoxifen, a leading selective estrogen receptor modulator, empowers advanced breast cancer research and genetic engineering through its dual action in hormone signaling and CreER-mediated gene knockout. This article details experimental protocols, workflow optimizations, and troubleshooting strategies that harness Tamoxifen’s full potential, guided by the latest peer-reviewed findings.

• Mianserin HCl: Translating 5-HT2 Antagonism Into Research Im

  2026-07-08

  Explore how Mianserin Hydrochloride’s multi-receptor antagonism and unique inclusion complex chemistry unlock new translational opportunities for psychiatric disorder and antipathogenic research. Anchored in clinical trial evidence, this article offers strategic guidance and mechanistic insight for innovative research design, while highlighting APExBIO’s rigorously validated compound.

• Caffeine in Translational Workflows: Cancer Inhibition & Met

  2026-07-08

  Caffeine (1,3,7-trimethylpurine-2,6-dione) stands out for its dual capacity to inhibit cancer cell lines and modulate energy metabolism, making it indispensable for experimental oncology and metabolic research. This guide delivers actionable workflow enhancements, troubleshooting insights, and highlights from pioneering studies to maximize the impact of APExBIO’s high-purity caffeine in your lab.

• DNase I (RNase-free): Precision DNA Removal for RNA Workflow

  2026-07-07

  DNase I (RNase-free) enables selective DNA digestion in RNA extraction, in vitro transcription, and RT-PCR by exploiting its cation-dependent endonuclease activity. This ribonuclease-free enzyme, supplied by APExBIO, ensures high-fidelity sample preparation and is benchmarked for chromatin and hybrid substrate versatility.

• DAPT (GSI-IX): Optimizing Notch Pathway Research Workflows

  2026-07-07

  DAPT (GSI-IX) empowers advanced modeling of the Notch signaling pathway, unlocking precise control in neurodegenerative, cancer, and stem cell organoid research. This article delivers actionable setup tips, protocol refinements, and troubleshooting strategies that translate molecular insights into reproducible experimental success.

• Applied Use of Protease Inhibitor Cocktail EDTA-Free in Prot

  2026-07-06

  Unlock robust, reproducible protein analysis with APExBIO's Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). Its EDTA-free design ensures compatibility with phosphorylation-sensitive assays and advanced workflows, positioning it as an industry leader for precise protease inhibition. Discover actionable protocol enhancements and troubleshooting tips for optimal protein integrity.

• Mianserin HCl: Mechanistic Leverage for Psychiatric Research

  2026-07-06

  This thought-leadership article explores Mianserin Hydrochloride (Mianserin HCl) as a next-generation 5-HT2 receptor antagonist, elucidating its mechanistic foundations, translational research protocols, and cross-domain potential in psychiatric and antipathogenic applications. Integrating primary literature, competitive insights, and APExBIO’s product intelligence, the article equips translational researchers with actionable strategies for leveraging Mianserin HCl in advanced neuroscience workflows.

• Staurosporine: Applied Workflows for Kinase Inhibition & Apo

  2026-07-05

  Staurosporine is the gold-standard broad-spectrum serine/threonine protein kinase inhibitor, enabling precise dissection of apoptosis and angiogenic signaling in cancer research. This guide delivers actionable protocols, troubleshooting insights, and the latest translational perspectives, including workflow innovations inspired by recent metastasis studies.

• Reliable Immunoassays with HRP Goat Anti-Mouse IgG (H+L) Ant

  2026-07-04

  This article addresses core challenges in cell viability and immunodetection workflows, demonstrating how the HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) delivers reproducible, high-sensitivity results. Scenario-driven analysis highlights protocol optimization, data interpretation, and vendor selection, making it a practical resource for researchers seeking robust, evidence-based solutions.

• Biomimetic Chromatography Models Pulmonary Drug Permeability

  2026-07-03

  This study rigorously evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC) coupled with mass spectrometry to model lung permeability of pharmaceuticals. Findings demonstrate robust, high-throughput screening capabilities and highlight the distinct advantages and limitations of each technique for antiretroviral drug research and broader drug development.

15684 records 1/1046 page Next 12345 下5页 Last page